APEPTICO granted Orphan Drug Designation by EMA and FDA

18th January, 2013, Vienna, Austria: APEPTICO Forschung und Entwicklung GmbH, a biotechnology company developing novel…

IMP: A molecular assembly line brings muscles into shape

Scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria and at the University of Cologne,…

APEIRON closes regional licese agreement for antibody-based immunotherapy

Vienna, 18 January 2013: APEIRON Biologics AG (Apeiron) today announced the closing of its first transaction in its…

IMP Scientists shed light on the “dark matter” of DNA

In each cell, thousands of regulatory regions control which genes are active at any time. Scientists at the Research…

MedUni Wien: Rheuma-Medikament wirkt auch bei halbierter Dosis

Sorry, this entry is only available in German!

Uni Wien: Erfolgreiche NachwuchswissenschafterInnen

Sorry, this entry is only available in German!

Astellas: Uro-Onkologische Forschung auf den Punkt gebracht

Sorry, this entry is only available in German!

MedUni Wien: Neue PRIZE-Prototypenförderung erstmals vergeben

Sorry, this entry is only available in German!